Olinciguat + Matching Placebo
Phase 2Terminated 0 views this week 0 watching💤 Quiet
Interest: 17/100
17
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Achalasia
Conditions
Achalasia
Trial Timeline
Apr 6, 2017 → May 1, 2018
NCT ID
NCT02931565About Olinciguat + Matching Placebo
Olinciguat + Matching Placebo is a phase 2 stage product being developed by Cyclerion Therapeutics for Achalasia. The current trial status is terminated. This product is registered under clinical trial identifier NCT02931565. Target conditions include Achalasia.
Hype Score Breakdown
Clinical
12
Activity
0
Company
5
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02931565 | Phase 2 | Terminated |
Competing Products
1 competing product in Achalasia
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Mirabegron 50 MG + Placebo | Astellas Pharma | Phase 1 | 21 |